Skip to main content

Higher Cardiovascular Risks with Systemic Lupus Erythematosus

The Journal of the American College of Cardiology has published the results of a study showing that patients with systemic lupus erythematosus (SLE) have an increased risk of heart failure (HF) and other long-term cardiovascular outcomes. 

Data taken from Danish administrative registries, compared CV outcomes between SLE patients (1996 to 2018 without baseline CV disease) and age-, sex-, and comorbidity-matched community control subjects.  A total of 3,411 SLE patients (median age: 44.6 years) was compared with 13,644 control subjects.

After a median follow-up of 8.5 years, Lupus patients had a 50% to 300% increased 10-year risks of the following (compared with controls):

  • Heart failure, 3.71% SLE vs 1.94% controls
  • Atrial fibrillation, 4.35% SLE vs. 2.82% controls
  • Ischemic stroke, 3.75% SLE vs. 1.92% controls
  • Myocardial infarction, 2.17% SLE vs. 1.49% controls
  • Venous thromboembolism, 6.03% SLE vs. 1.68% controls
  • Risk of implantable cardioverter-defibrillator implantation/ventricular arrhythmias/cardiac arrest, 0.89% SLE vs 0.30%

Lupus patients who developed HF, had a 50% higher mortality than did HF patients without SLE.

 

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Disclosures
The author has no conflicts of interest to disclose related to this subject